Actavis prepares to sell four-part offering of senior notes

By Aleesia Forni

Virginia Beach, June 10 – Actavis plc’s indirect subsidiary, Actavis Funding SCS, plans to offer senior notes in three-, five-, 10- and 30-year tranches, according to a company press release.

The notes will be sold via Rule 144A and Regulation S.

Proceeds will be used to fund the acquisition of Forest Laboratories, Inc., to refinance Warner Chilcott’s 7.75% senior notes due 2018 and to pay related fees and expenses and for general corporate purposes.

Actavis is a pharmaceutical company with headquarters in Dublin.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.